These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9282979)
1. Hyperdynamic circulation of cirrhotic rats: role of substance P and its relationship to nitric oxide. Chu CJ; Lee FY; Wang SS; Chang FY; Tsai YT; Lin HC; Hou MC; Wu SL; Tai CC; Lee SD Scand J Gastroenterol; 1997 Aug; 32(8):841-6. PubMed ID: 9282979 [TBL] [Abstract][Full Text] [Related]
2. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride. Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Chan CC; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):196-204. PubMed ID: 10746415 [TBL] [Abstract][Full Text] [Related]
3. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide. Chu CJ; Lee FY; Wang SS; Lu RH; Tsai YT; Lin HC; Hou MC; Chan CC; Lee SD Clin Sci (Lond); 1997 Sep; 93(3):219-25. PubMed ID: 9337636 [TBL] [Abstract][Full Text] [Related]
4. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics. Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197 [TBL] [Abstract][Full Text] [Related]
5. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414 [TBL] [Abstract][Full Text] [Related]
7. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Niederberger M; Martin PY; Ginès P; Morris K; Tsai P; Xu DL; McMurtry I; Schrier RW Gastroenterology; 1995 Nov; 109(5):1624-30. PubMed ID: 7557147 [TBL] [Abstract][Full Text] [Related]
8. Role of endotoxaemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension. Lee FY; Wang SS; Yang MC; Tsai YT; Wu SL; Lu RH; Chan CY; Lee SD J Gastroenterol Hepatol; 1996 Feb; 11(2):152-8. PubMed ID: 8672761 [TBL] [Abstract][Full Text] [Related]
9. Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats. Li Y; Song D; Zhang Y; Lee SS Gut; 2003 Feb; 52(2):293-9. PubMed ID: 12524416 [TBL] [Abstract][Full Text] [Related]
10. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis. Xu L; Carter EP; Ohara M; Martin PY; Rogachev B; Morris K; Cadnapaphornchai M; Knotek M; Schrier RW Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1110-5. PubMed ID: 11097630 [TBL] [Abstract][Full Text] [Related]
11. Hyperdynamic circulation in prehepatic portal hypertension: role of tumor necrosis factor-alpha. Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Wu SL; Tai CC; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):145-50. PubMed ID: 9198288 [TBL] [Abstract][Full Text] [Related]
12. Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats. Wu ZY; Chen XS; Qiu JF; Cao H World J Gastroenterol; 2005 Feb; 11(5):752-5. PubMed ID: 15655838 [TBL] [Abstract][Full Text] [Related]
13. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance. Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066 [TBL] [Abstract][Full Text] [Related]
14. Augmented endogenous nitric oxide production in partial portal vein-ligated rats. Hori N; Takahashi H; Okanoue T; Sawa Y; Mori T; Takami S; Yoshimura M; Kashima K Clin Exp Pharmacol Physiol; 1995 Aug; 22(8):506-11. PubMed ID: 7586705 [TBL] [Abstract][Full Text] [Related]
15. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. Fernández-Rodriguez CM; Prieto J; Quiroga J; Zozoya JM; Andrade A; Núñez M; Sangro B; Penas J Hepatology; 1995 Jan; 21(1):35-40. PubMed ID: 7528711 [TBL] [Abstract][Full Text] [Related]
16. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation. Lee FY; Lu RH; Tsai YT; Lin HC; Hou MC; Li CP; Liao TM; Lin LF; Wang SS; Lee SD Scand J Gastroenterol; 1996 May; 31(5):500-5. PubMed ID: 8734349 [TBL] [Abstract][Full Text] [Related]
17. Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function. Yang YY; Lin HC; Lee WC; Huang YT; Hou MC; Lee FY; Chang FY; Lee SD J Gastroenterol Hepatol; 2003 Oct; 18(10):1156-61. PubMed ID: 12974902 [TBL] [Abstract][Full Text] [Related]
18. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension. Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939 [TBL] [Abstract][Full Text] [Related]
19. Increased blood flow through the portal system in cirrhotic rats. Vorobioff J; Bredfeldt JE; Groszmann RJ Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534 [TBL] [Abstract][Full Text] [Related]
20. Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis. Bhimani EK; Serracino-Inglott F; Sarela AI; Batten JJ; Mathie RT J Surg Res; 2003 Jul; 113(1):172-8. PubMed ID: 12943827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]